A share price of Outset Medical Inc [OM] is currently trading at $4.82, up 14.49%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The OM shares have gain 21.11% over the last week, with a monthly amount glided 23.27%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Outset Medical Inc [NASDAQ: OM] stock has seen the most recent analyst activity on June 21, 2024, when RBC Capital Mkts upgraded its rating to a Outperform and also boosted its price target to $6 from $5. Previously, BTIG Research started tracking the stock with Buy rating on April 08, 2024, and set its price target to $6. On April 05, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $6 on the stock. RBC Capital Mkts downgraded its rating to a Sector Perform and decreased its price target to $6 on January 12, 2024. BofA Securities downgraded its rating to a Underperform and reduced its price target to $3 on October 13, 2023. In a note dated November 11, 2022, RBC Capital Mkts initiated an Outperform rating and provided a target price of $23 on this stock.
Outset Medical Inc experienced fluctuations in its stock price throughout the past year between $1.92 and $20.75. Currently, Wall Street analysts expect the stock to reach $11.6 within the next 12 months. Outset Medical Inc [NASDAQ: OM] shares were valued at $4.82 at the most recent close of the market. An investor can expect a potential return of 140.66% based on the average OM price forecast.
Analyzing the OM fundamentals
Trailing Twelve Months sales for Outset Medical Inc [NASDAQ:OM] were 125.08M which represents -15.83% decline. Gross Profit Margin for this corporation currently stands at 0.25% with Operating Profit Margin at -1.3%, Pretax Profit Margin comes in at -1.35%, and Net Profit Margin reading is -1.35%. To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -1.22 and Total Capital is -0.55. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.43 points at the first support level, and at 4.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.03, and for the 2nd resistance point, it is at 5.23.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Outset Medical Inc [NASDAQ:OM] is 6.42. As well, the Quick Ratio is 5.32, while the Cash Ratio is 0.64. Considering the valuation of this stock, the price to sales ratio is 1.99, the price to book ratio is 2.67.
Transactions by insiders
Recent insider trading involved Brottem John L., General Counsel, that happened on Jun 12 ’24 when 10569.0 shares were sold. Director, GROSSMAN D KEITH completed a deal on Jun 03 ’24 to sell 38117.0 shares. Meanwhile, Chair and CEO Trigg Leslie sold 5237.0 shares on May 16 ’24.
